16-75647928-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000300086.5(TERF2IP):c.46C>T(p.His16Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00000496 in 1,612,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H16R) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000300086.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TERF2IP | NM_018975.4 | c.46C>T | p.His16Tyr | missense_variant | 1/3 | ENST00000300086.5 | NP_061848.2 | |
TERF2IP | XM_047434216.1 | c.46C>T | p.His16Tyr | missense_variant | 1/2 | XP_047290172.1 | ||
TERF2IP | NR_144545.2 | n.156C>T | non_coding_transcript_exon_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TERF2IP | ENST00000300086.5 | c.46C>T | p.His16Tyr | missense_variant | 1/3 | 1 | NM_018975.4 | ENSP00000300086 | P1 | |
KARS1 | ENST00000566560.5 | n.176+540G>A | intron_variant, non_coding_transcript_variant | 1 | ||||||
TERF2IP | ENST00000653858.1 | c.46C>T | p.His16Tyr | missense_variant | 1/4 | ENSP00000499565 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250248Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135402
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1459858Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 725926
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 28, 2023 | The p.H16Y variant (also known as c.46C>T), located in coding exon 1 of the TERF2IP gene, results from a C to T substitution at nucleotide position 46. The histidine at codon 16 is replaced by tyrosine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 01, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with TERF2IP-related conditions. This variant is present in population databases (rs371551592, gnomAD 0.01%). This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 16 of the TERF2IP protein (p.His16Tyr). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at